Member Info for AquaeSulis01

Extracted from today's Pearson RNS where they flag the increasing move to digital learning.

Virtual Schools
In Connections Academy, our Virtual Schools business, revenue grew strongly due to growth in enrolments in existing and new schools. We have seen a surge in applications, up 61% in the first half compared to 2019, as many explore full time digital learning for the first time. We expect a portion of these applications to translate into increased enrolments for the 2020/2021 school year. Pearson is well placed to benefit from the increased interest in and appetite for online learning. We are increasing the capacity in our existing schools as well as seeing potential interest from new states which have not previously considered virtual schooling as a choice for students.



Three new full-time online, state-wide partner schools will open in the 2020-21 school year. Combined with two contract exits this will bring the total partner schools to 43 in 29 states. Additionally, the online private school, Pearson Online Academy continues to serve students across the globe.

Well Swaplebar, let's hope you have had your eyebrows trimmed bow that the hairdressers are open again and that you are not sporting a pair of Dennis Healeys down to your knees :)

Far fetched scenario. Next production update sta tes that oil production has gone up whilst water cut has reduced. Share price shoots up and shorte rs sizzle. Simples??

https://www.powermag.com/e-on-debuts-resilience-as-a-service-for-remote-markets/

E.ON Debuts ‘Resilience-as-a-Service’ for Remote Markets
German energy supplier E.ON is collaborating with UK energy firms Scottish and Southern Electricity Networks (SSEN) and Costain Group to roll out an innovative business model that monetizes resilience and grid stability services to remote areas.

HS2 Gaining Momentum

https://www.theconstructionindex.co.uk/news/view/mace-dragados-takes-over-euston-site-seeks-suppliers

HS2 Euston area client director Laurence Whitbourn said: “The construction of HS2 is rapidly increasing in pace and the handover of the Euston site to our construction partner Mace Dragados is another important milestone in the programme to build Britain’s new low-carbon, high speed railway.

“The progress in our work comes at a good time as we help support the British economy and construction sector as part of the post-pandemic economic recovery creating new jobs and providing contract opportunities.”

Dundee Uni and Costain join construction efficiency project
2 hours Costain and the University of Dundee are part of a newly launched £16m programme that will harness historic data with the aim of boosting the efficiency of major infrastructure projects.

https://www.theconstructionindex.co.uk/news/view/dundee-uni-and-costain-join-project-to-help-drive-construction-efficiency

https://www.costain.com/news/news-releases/costain-driving-industry-innovation-as-strategic-partner-in-uk-government-s-new-living-lab-programme/

Tyson, the comparison with Sirius is illogical. Sirius had all the expense to complete their mine , no revenue coming in and hence no money to fund it so had little choice but to sell for peanuts. Hurricane are generating considerable revenue and hence profit to cover their immediate operations. The issue is whether they can keep their current assets producing at a steady state, if they do then they will build confidence in the investment community that fractured basement can be successfully exploited and attract the necessary funding to fully exploit their reserves. In addition, the largest stakeholder is Kerogen and they will not sell out cheaply in the absence of a smoking gun held to their heads

The big one for OO is the Substantial new pipeline of opportunities to develop Covid challenges studies £35m-£70m and in order for that to be delivered, the development of a mild strain that infects without leading to serious symptoms will need to be manufactured and it appears we are in a race to produce it.

https://www.sciencemag.org/news/2020/07/controversial-human-challenge-trials-covid-19-vaccines-gain-support

Making the challenge virus will likely take at least until September, Turner says. At that point, according to the WHO proposal, trials should recruit volunteers to test three different doses to find one that causes mild respiratory illness in 70% of people. WHO estimates it will take 2 months after viral strains are made and characterized to launch a challenge study.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30438-2/fulltext
Conclusions
COVID-19 poses an extraordinary global health threat for which vaccines are urgently needed. Among other benefits, COVID-19 human challenge studies could accelerate vaccine development, helping to test multiple candidate vaccines. More ethically acceptable study designs would involve young healthy participants in inpatient settings with immediate access to high-quality health care and strict infection control measures. All risks should be minimised to the extent that risk minimisation would not unduly compromise potential research benefits. Consultation with scientific experts, prospective participants, and the wider community will help to determine the extent to which residual risks are acceptable and outweighed by the expected benefits.

The odds of winning the Jackpot on the lottery are indeed 1 to 4,000,000., but the chance of winning ANY prize*: 1 in 9.2 (nearly 11%), you don't need the jackpot to send a sp north that is already priced to lose.

Yep, one strike and we're in a much happier place. Not a share to invest too heavily in but one piece of good news and all the risks very quickly turn into opportunities and we do hold more than one "lottery ticket"

Also wouldn't completely write off fluorspar, with the trade war with China ramping up and China having control of 70% of the market, could well see the price rising enough to warrant lower grade extraction, plus will Sweden have a re-think re granting permission for extraction there now that their economy, along with the rest of the world has been severly compromised by Covid?

http://www.branduk.net/treasure-hunting-in-nevada-with-tertiary-minerals-walker-lane-marks-the-spot-for-gold/

The fluorspar will be mothballed until/ unless prices r ise to warrant its extraction and this bad news is already reflected in the share price. The company has 750k in the bank a market cap of just 1.9 million and a lot of other mining prospects with more positive updates

Vox Markets podcast where Alan Green discusses today's update with Justin Waite.

****************************/articles/tungsten-corp-trading-update-and-alan-green-on-4-stocks-4fe03f7/

If they do you can put at least one nought on the sp

ffs it isn't rocket science, if the watercut is shown to be stable at the next operating update this flies by approx 50% if not this drops sub 4p

Actual report for those that want to read the detail

https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620316044.pdf

Lancet report out and we need those Human Challenge Studies
https://www.cnbc.com/2020/07/20/oxford-universitys-coronavirus-vaccine-shows-positive-immune-response-in-an-early-trial.html

While Oxford’s data is promising, scientists warn that questions remain about how the human body responds once it’s been infected with the virus. The answers, they say, may have important implications for vaccine development, including how quickly it can be deployed to the public.

One critical question among scientists is whether antibodies produced in response to Covid-19 offer protection against getting infected again.

Scientists hope the antibodies provide some degree of protection against getting Covid-19, but they can’t say that definitively yet since the virus was first discovered just six months ago. It hasn’t been studied in-depth and some patients appear to have been reinfected after recovering from Covid-19.

Probably based on research by EY carried out for the NHS

https://www.digitalhealth.net/2019/07/nhs-data-worth-9-6bn-per-year-says-ernst-young/

I suspect slight dip in so may be due to the headlines re a fingerprint antibody test developed by Oxford University. However, promising as it sounds read past the headline and you find that it will not be available until the end of the year. https://www.dailymail.co.uk/sciencetech/article-8535625/Game-changing-antibody-test-takes-20-minutes-passes-trials-98-6-accuracy.html

Why do people fear further doom and gloom when the sp languishes following a bad RNS and before a fresh RNS with a meaningful update is produced? Post April when the oil price collapsed and prior to the 22nd May RNS which announced the well 7z issues that reduced the 20K bopd forecast, the price operated in a range between 9.79-12.30 up and down, since the bad news RNS it has fluctuated between a closing price of 5.67 - 8.85, nothing has changed or will change until the promised RNS sometime post the 14 day test period with the ESP assistance announced in the 8th July RNS. When that RNS is received, the sp will either rerate upwards towards the 9-12 p range if positive or drop further. By my calculations, the 14 day test period will be up on 22 nd Jul, in the interim no-one knows or is privvy to meaningful insider info I would suggest.